Regeneron Pharmaceuticals total change in assets/liabilities for the twelve months ending March 31, 2025 was $-1.489B, a 414.52% decline year-over-year.
Regeneron Pharmaceuticals annual total change in assets/liabilities for 2024 was $-0.618B, a 557.07% increase from 2023.
Regeneron Pharmaceuticals annual total change in assets/liabilities for 2023 was $-0.094B, a 61.32% decline from 2022.
Regeneron Pharmaceuticals annual total change in assets/liabilities for 2022 was $-0.243B, a 87.3% decline from 2021.
Regeneron Pharmaceuticals Total Change in Assets/Liabilities 2010-2025 | REGN